What's wrong with acellular pertussis vaccines?
作者信息
Wiedermann Bernhard L
机构信息
Division of Infectious Diseases, Children's National Medical Center, Washington, DC 20010, USA.
出版信息
Clin Ther. 2013 Feb;35(2):115-8. doi: 10.1016/j.clinthera.2013.01.006. Epub 2013 Jan 31.
Abstract
摘要
相似文献
1
What's wrong with acellular pertussis vaccines?无细胞百日咳疫苗有什么问题？
Clin Ther. 2013 Feb;35(2):115-8. doi: 10.1016/j.clinthera.2013.01.006. Epub 2013 Jan 31.
2
Why do pertussis vaccines fail?百日咳疫苗为何会失效？
Pediatrics. 2012 May;129(5):968-70. doi: 10.1542/peds.2011-2594. Epub 2012 Apr 23.
3
Priming with whole-cell versus acellular pertussis vaccine.全细胞百日咳疫苗与无细胞百日咳疫苗的预充。
N Engl J Med. 2013 Feb 7;368(6):581-2. doi: 10.1056/NEJMc1212006.
4
Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.在韩国，一项比较联合使用无细胞百白破、灭活脊髓灰质炎（DTaP-IPV）疫苗与分别单独使用百白破（DTaP）和脊髓灰质炎（IPV）疫苗的免疫原性和安全性的随机对照研究：在婴儿中进行的研究。
Vaccine. 2011 Feb 11;29(8):1551-7. doi: 10.1016/j.vaccine.2010.12.094. Epub 2011 Jan 6.
5
Pertussis vaccines for adolescents and adults.青少年及成人用百日咳疫苗
Pediatrics. 2005 Sep;116(3):755-6. doi: 10.1542/peds.2005-0960.
6
Age range widens for pertussis vaccine: boosters advised for adolescents and adults.
JAMA. 2006 Feb 22;295(8):871-2. doi: 10.1001/jama.295.8.871.
7
8
[Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults].用于青少年和成人的无细胞百日咳疫苗的免疫原性和反应原性
Przegl Epidemiol. 2012;66(1):99-105.
9
[Assessment of postvaccinal response in children past pertussis].[百日咳后儿童疫苗接种后反应的评估]
Wiad Lek. 2006;59(11-12):819-22.
10
Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.青少年免疫接种最新情况：百日咳及破伤风-白喉-无细胞百日咳疫苗的疗效、安全性和临床应用综述
J Pediatr Health Care. 2006 Jul-Aug;20(4):229-37. doi: 10.1016/j.pedhc.2005.12.011.
Zotero 插件